MedTrace Logo

Human Milk Oligosaccharides (HMOs) for Irritable Bowel Syndrome (IBS)

NCT05205785 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 204

Last updated 2024-08-07

No results posted yet for this study

Summary

To assess the effects of a Human Milk Oligosaccharide mix given once daily for 12 weeks on stool consistency and abdominal pain compared to placebo in individuals with Irritable Bowel Syndrome (IBS).

Conditions

  • Irritable Bowel Syndrome
  • IBS - Irritable Bowel Syndrome

Interventions

DIETARY_SUPPLEMENT

Human Milk Oligosaccharide Mix

Subjects takes 5.5 g of powder mixed in water once a day for 12 weeks.

OTHER

Placebo

The placebo to be used in this trial is 5.5 g of powdered dextrose powder in a single-serve stick pack. The participants will be instructed to mix the product in a 4-6 oz glass of water and consume in the morning once a day for 12 weeks.

Sponsors & Collaborators

  • DSM Nutritional Products, Inc.

    lead INDUSTRY

Principal Investigators

  • Martin Buckley, M.D. · Atlantia Clinical Trials

  • Seema Mody, MSc · DSM

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-22
Primary Completion
2024-03-05
Completion
2024-06-24

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05205785 on ClinicalTrials.gov